Evidence map›Paper›PMID 35594336›Full record

ReviewAnnals of medicine2022

Pathophysiology and mechanism of long COVID: a comprehensive review.

D Castanares-Zapatero, P Chalon, L Kohn, M Dauvrin, J Detollenaere, C Maertens de Noordhout, C Primus-de Jong, I Cleemput, K Van den Heede

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Annals of medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07627815 (Phase II, Proof of Concept, Open-Label, Randomized-Controlled Trial Evaluating the Efficacy and Safety of PARAGON Novel Metabolic Regulator Formula), which is not on this map. Cited by 319 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
319citing papers in PubMed, 10 pooled it
72.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07627815 phase2recruitingnot on this mapstarted 2026, after this paper: background citation

Phase II, Proof of Concept, Open-Label, Randomized-Controlled Trial Evaluating the Efficacy and Safety of PARAGON Novel Metabolic Regulator Formula (PNMR) in the Management of Long COVID

TypeinterventionalSponsorParagonClinicals Inc.Ran2026 to 2026Enrolled82ConditionsLong COVIDArmsParagon Novel Metabolic Regulator (PNMR), Dietary and Lifestyle Recommendations
3 · Its place in the literature

Who cites it

319 citing papers in PubMed, 10 syntheses or guidelines pooled it, 602 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Post-COVID-19 conditions: a systematic review on advanced magnetic resonance neuroimaging findings.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Pooled it
  9. Pathophysiological Mechanisms in Long COVID: A Mixed Method Systematic Review.International journal of environmental research and public health · 2024
    Pooled it
  10. Pooled it
  11. Trial
  12. Profiles of Individuals With Long COVID Reporting Persistent Cognitive Complaints.Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2025
    Trial
  13. Trial
  14. Personalised Health Behaviour Support Programme in Adults With Post-COVID Syndrome: A Randomised, Controlled Pilot Feasibility Trial.Health expectations : an international journal of public participation in health care and health policy · 2024
    Trial
  15. Trial
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

259 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

D Castanares-ZapateroCentre Administratif du Botanique, Belgian Health Care Knowledge Centre (KCE), Brussels, Belgium.ORCID 0000-0001-7112-2070
P ChalonCentre Administratif du Botanique, Belgian Health Care Knowledge Centre (KCE), Brussels, Belgium.
L KohnCentre Administratif du Botanique, Belgian Health Care Knowledge Centre (KCE), Brussels, Belgium.
M DauvrinCentre Administratif du Botanique, Belgian Health Care Knowledge Centre (KCE), Brussels, Belgium.
J DetollenaereCentre Administratif du Botanique, Belgian Health Care Knowledge Centre (KCE), Brussels, Belgium.
C Maertens de NoordhoutCentre Administratif du Botanique, Belgian Health Care Knowledge Centre (KCE), Brussels, Belgium.
C Primus-de JongCentre Administratif du Botanique, Belgian Health Care Knowledge Centre (KCE), Brussels, Belgium.
I CleemputCentre Administratif du Botanique, Belgian Health Care Knowledge Centre (KCE), Brussels, Belgium.
K Van den HeedeCentre Administratif du Botanique, Belgian Health Care Knowledge Centre (KCE), Brussels, Belgium.
Belgian Health Care Knowledge Centre (KCE) · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAfter almost 2 years of fighting against SARS-CoV-2 pandemic, the number of patients enduring persistent symptoms long after acute infection is a matter of concern. This set of symptoms was referred to as "long COVID", and it was defined more recently as "Post COVID-19 condition" by the World health Organization (WHO). Although studies have revealed that long COVID can manifest whatever the severity of inaugural illness, the underlying pathophysiology is still enigmatic.

aimTo conduct a comprehensive review to address the putative pathophysiology underlying the persisting symptoms of long COVID.

methodWe searched 11 bibliographic databases (Cochrane Library, JBI EBP Database, Medline, Embase, PsycInfo, CINHAL, Ovid Nursing Database, Journals@Ovid, SciLit, EuropePMC, and CoronaCentral). We selected studies that put forward hypotheses on the pathophysiology, as well as those that encompassed long COVID patients in their research investigation.

resultsA total of 98 articles were included in the systematic review, 54 of which exclusively addressed hypotheses on pathophysiology, while 44 involved COVID patients. Studies that included patients displayed heterogeneity with respect to the severity of initial illness, timing of analysis, or presence of a control group. Although long COVID likely results from long-term organ damage due to acute-phase infection, specific mechanisms following the initial illness could contribute to the later symptoms possibly affecting many organs. As such, autonomic nervous system damage could account for many symptoms without clear evidence of organ damage. Immune dysregulation, auto-immunity, endothelial dysfunction, occult viral persistence, as well as coagulation activation are the main underlying pathophysiological mechanisms so far.

conclusionEvidence on why persistent symptoms occur is still limited, and available studies are heterogeneous. Apart from long-term organ damage, many hints suggest that specific mechanisms following acute illness could be involved in long COVID symptoms. KEY MESSAGESLong-COVID is a multisystem disease that develops regardless of the initial disease severity. Its clinical spectrum comprises a wide range of symptoms.The mechanisms underlying its pathophysiology are still unclear. Although organ damage from the acute infection phase likely accounts for symptoms, specific long-lasting inflammatory mechanisms have been proposed, as well.Existing studies involving Long-COVID patients are highly heterogeneous, as they include patients with various COVID-19 severity levels and different time frame analysis, as well.

Indexed as

COVID-19HumansPandemicsPost-Acute COVID-19 SyndromeSARS-CoV-2COVID-19Long COVIDpathologyphysiologypost-COVID-19 condition

Identifiers

PMID35594336
PMCPMC9132392
OpenAlexW4281250656

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.